Chief Business Officer and Commercial Strategist, Biologics Consulting
Steven M. Walker serves as the Chief Business Officer (CBO) and Commercial Strategist at Biologics Consulting. Steven has over 20 years of biopharmaceutical business and research experience, with a focus in immunology, respiratory, dermatology, vaccine, cardiovascular disease and neuroscience. Steven’s subject matter expertise is focused on business strategy and product / portfolio commercialization. Prior to joining Biologics Consulting, he played a leadership role within Respiratory, Inflammation and Autoimmune – New Product Planning (NPP) at MedImmune, Specialty Care Division of AstraZeneca.
Other areas of professional experience include leadership of Cross Franchise Initiatives for the Infectious Disease division and Marketing Head of an Influenza vaccine. Steven also served multiple roles of increasing responsibility at Genentech, such as Senior Marketer and Regional Sales Director, with responsibility for respiratory and dermatology biologics. He also worked at Schering-Plough Corporation, before joining Genentech and served in roles and functions of progressing responsibility ranging from Corporate Strategy, Marketing, Sales and Specialty Sales Management.
Before entering the biopharmaceutical industry, Steven spent time working in the life-sciences internationally in Barbados at the Virgin Island Center of Chronic Disease Research focused on diabetes research, as well as working at the University of Pittsburgh Medical Center (UPMC) – department of Orthopedic Surgery, as a research surgical intern.
Steven is a Corporate Advisor for the Cellandtech Group – a life-science strategy firm and a member of Maryland Tech Council’s Board of Directors. He holds a B.S. in Neuroscience from the University of Pittsburgh, M.B.A. from Joseph M. Katz Graduate School of Business at University of Pittsburgh, and a M.H.A. from the Graduate School of Public Health at University of Pittsburgh.